Trials / Completed
CompletedNCT02470715
Identifying Molecular Drivers of Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 579 (actual)
- Sponsor
- Avera McKennan Hospital & University Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.
Detailed description
This study involves looking at the DNA, RNA, proteins, and metabolites in blood and tissue samples collected from subjects and linking them to their health information. By doing so, researchers hope to discover the underlying molecular causes of human diseases with the hope that this information can be used for the development of diagnostic tests and more effective treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Molecular profile | Patients and their treating physician will obtain the patient's genetic risk assessment |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-05-22
- Completion
- 2018-05-22
- First posted
- 2015-06-12
- Last updated
- 2018-05-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02470715. Inclusion in this directory is not an endorsement.